Figure S2 (related to Figure 4).

TNF plus Z-VAD treatment, growth curves. (A) Hace1
+/+ and hace1 -/-MEFs are treated with TNF (10ng/ml) plus Z-VAD (5µg/ml) for the indicated time points. Cell viability was determined in triplicates (mean values +/-SD). (B) Growth curve measurements of hace1 +/+ , hace1 -/-and hace1 -/-ripk3 -/-MEFs. Cells were trypsinized and counted using a Casy Counter ® every day for 5 days. Mean values (+/-SD) were determined in quadruplicate cultures. 
Identification of Hace1 ubiquitylation targets.
(A) HACE1 E3 ligase activity was determined by in vitro ubiquitylation reactions using the indicated E2 enzymes. Complete indicates 100nM recombinant His-HACE1, 1µM of the respective E2 enzyme, 100µg/ml 200nM ubiquitin E1 enzyme and ATP (1mM) . Reactions were incubated at 30°C for 1 hr. Control reactions in the absence of ATP (no ATP) or the absence of (A) In vitro HACE1 ubiquitylation reactions (complete = HACE1, Ubc13, E1, ubiquitin, and ATP) in the presence of 100mM recombinant TRAF2 (+ TRAF2) or absence of TRAF2 (-TRAF2) as substrate. Reactions in the absence of HACE1 (no HACE1) or in the presence of ubiquitin-K63-mutant (K63R) are shown as controls. Ubiquitination reaction was performed at 30ºC for 1 hr. TRAF2 was then immunoprecipitated from the complete reaction and probed for either total ubiquitin or using an antibody that specifically detects ubiquitin K63 branched chains. (B) TRAF2 was immunoprecipitated from hace1 +/+ and hace1 -/-MEFs treated with TNF (10ng/ml) (+) or left untreated (-). Immunoblotting was performed using an antibody specific to the ubiquitin K63-chain. (C) TRAF2 was immunoprecipitated from hace1 +/+ and hace1 -/-MEFs treated with TNF (+) or left untreated (-) as described in Figure S7B . Western blotting was performed using an antibody specific to ubiquitin K48-linked chains. TRAF2 control levels are shown in Figure S7B .
MEFs re-expressing either full length wild type HACE1 or its ligase-dead form C876S were stimulated with TNF (10ng/ml) or left untreated. TRAF2 was immunoprecipitated and total TRAF2 and TRAF2 K63 ubiquitylation (poly-Ub-K63) analyzed by Western blot. Levels of wild type and C876S HACE1 were determined using anti-HA antibody. (E) hace1 +/+ MEFs were transfected with HACE1 specific siRNA or with scrambled siRNA. Following TNF (10ng/ml) stimulation, TRAF2 was immunoprecipitated and analyzed as in Figure S7B -7D. HACE1 and TRAF2 levels were determined using specific antibodies. (A) Immunoprecipitation of TRAF2 from lysates of hace1 +/+ MEFs with (+) and without (-) TNF (10ng/ml) stimulation. Endogenous HACE1 interacting with TRAF2 was detected using specific antibodies. (B) Wild type MEFs overexpressing HAtagged HACE1 were stimulated with TNF (10ng/ml) (+) or left untreated (-). HACE1 was immunoprecipitated using an anti-HA antibody and immunoprecipitates probed with antibodies to detect HA-HACE1 and TRAF2. Total TRAF2 is shown to control for the input. (C) Complex I was immunoprecipitated as described in Figure 5A . FlagIPs and input lysates were probed with antibodies to IKKγ, RIP1 kinase, TRAF2, and HACE1. RIP1 kinase phosphorylation (p-RIP1) is indicated. (D) Cells were stimulated with Flag-hTNF for the indicated time. Immediately before Flag-IP, FlaghTNF was added to the lysates of untreated samples to allow analysis of the TNFR1 signaling complex also in unstimulated cells. Flag-IPs and input lysates were probed with antibodies against RIP1 and HACE1. (E) FACS histograms showing surface expression levels of TNFR1 (red lines) in hace1 +/+ and hace1 -/-MEFs. Background staining using an isotype control is shown in grey. (F-G) Quantification of the phosphorylated (F) and ubiquitylated RIP1 kinase (G) after TNF treatment as shown in Figure 5A . (H) Serial immunoprecipitation of K63-ubiquitylated proteins from the TNFR1 complex. Western blots were performed to detect the presence of ubiquitylated TRAF2; ubiquitylated RIP1 kinase is shown as control. +/+ and hace1 -/-MEFs were treated with the necroptotic trigger TNF (10ng/ml), BV6 (1µM), plus Z-VAD (5µg/ml) for the indicated time points followed by immunoprecipitation of Caspase-8 to assay for the formation of the Caspase-8/RIP1/RIP3 necrosome. Input lysates were assayed for the indicated proteins. Phosphorylated RIP1 (p-RIP1) is indicated. 
Supplemental Experimental Procedures
Western Blot Antibodies. Western blots were performed using the following specific antibodies: anti-β-Actin (100M4789, Sigma), anti- MABC604, Millipore) . Immunoprecipitations were performed according to the manufacturer's protocol. Serial IPs were performed after dissolving the first immunoprecipitated complex either in 6M urea (for TUBE-IP) or in 1% SDS (for TRAF2 IP) and subsequent dilution 1:25 (urea) and 1:10 (SDS) and reimmunoprecipitated as described in the figure legends. Cell numbers were determined and adjusted using a CASY counter (Roche Innovatis). All Western blot quantifications were calculated from scanned.tiff file using the ImageJ analysis software developed by NIH. Duo-Set ELISAs to detect Interleukin-6 concentrations in cell supernatants were performed according to manufacturer specifications (R&D Systems).
Detection of cell viability. In order to calculate cell viability, treated and control untreated cells were trypsinized at the indicated time points, harvested and stained with trypan blue to exclude dead cells. Cell numbers were determined using a hemocytometer. In addition, cells were washed twice with PBS, directly fixed on the Petri dish with 4% PFA and stained with crystal violet. All images were taken using a light microscope (Zeiss). Time lapse images of apoptotic and necroptotic MEFs were taken using the Live Cell Observer Axiovert 200M (Zeiss). Cells were left in the microscope 37ºC heated chamber for 1 hr prior the treatments with TNF and ActinomycinD or cycloheximide and phase contrast images taken before and every 2 hrs after treatment. The fluorogenic DEVDase substrate assay was carried out following previously described protocols (Vercammen et al., 1998) . MEFs were seeded in 6-plicates in a 96 wells plate at a density of 15 × 10 3 cells per well. The next day, after exposure to various treatments, the cells were lysed in 100µl of Caspase lysis buffer. Caspase activity was measured by incubating 50µl of the supernatant with 50 µl of 2 X cell-free system buffer containing 20 mM Hepes, pH 7.4, 440 mM mannitol, 136 mM sucrose, 4 mM NaCl, 5 mM KH 2 PO 4 , 4 mM MgCl 2 , 20 mM dithiothreitol, and 100 µM Ac-DEVD-MCA (Peptide, Scientific Marketing Associate,
